Skip to content

Evaluating Universal Adhesives in Cervical Lesions

Evaluation of the Clinical Performance of Universal Adhesives in Non-Carious Cervical Lesions: A Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07459374
Enrollment
30
Registered
2026-03-09
Start date
2024-03-19
Completion date
2028-03-19
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Lesion, Dental

Keywords

G2 Bond Universal, Scotchbond Universal Plus, Tokuyama Universal Bond II, Non-Carious Cervical Lesions

Brief summary

The aim of this randomized controlled clinical trial is to evaluate the 12-month clinical performance of restorations placed in NCCLs using universal adhesives with different compositions according to FDI criteria.

Detailed description

This controlled, randomized, single-blind clinical trial will compare the clinical effectiveness of three universal adhesive systems with different compositions in the restoration of non-carious cervical lesions. A total of 30 healthy volunteers aged 18-55 years will be included. Each participant must present with at least three vital posterior teeth with non-carious cervical lesions (≥3 lesions), with both enamel and dentin involvement and with antagonist teeth in occlusion. Each participant will receive restorations using all three adhesive systems in different teeth (split- mouth design). Randomization will be performed using a computer-generated randomization table (Research Randomizer Program). An experienced operator from the Department of Restorative Dentistry will perform all restorative procedures (AUT). Radiographs will be taken at baseline (before treatment) and at 12-, 24- and 36-month follow-up appointments to assess adaptation, marginal integrity, and proximity to the pulp. Additional radiographs will only be taken if clinically indicated (e.g., suspected endodontic involvement). Restorations will be evaluated immediately after placement, at 12-, 24- and 36-month using FDI evaluation criteria.

Interventions

DEVICEG2 Bond Universal, GC Europe N.V., Leuven, Belgium

G2 Bond Universal, GC Europe N.V., Leuven, Belgium

DEVICEScotchbond Universal Plus, 3M ESPE, St. Paul, MN, USA

Scotchbond Universal Plus, 3M ESPE, St. Paul, MN, USA

DEVICETokuyama Universal Bond II, Tokuyama Dental, Tokyo, Japan

Tokuyama Universal Bond II, Tokuyama Dental, Tokyo, Japan

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy individuals aged 18-55 years * No systemic condition contraindicating restorative treatment * Brushing teeth at least twice daily * At least 20 teeth in occlusion * At least three vital posterior teeth with non-carious cervical lesions and antagonist teeth * Completed initial periodontal therapy * Signed informed consent

Exclusion criteria

* Healthy individuals aged 18-55 years * No systemic condition contraindicating restorative treatment * Brushing teeth at least twice daily * At least 20 teeth in occlusion * At least three vital posterior teeth with non-carious cervical lesions and antagonist teeth * Completed initial periodontal therapy * Signed informed consent

Design outcomes

Primary

MeasureTime frameDescription
Restoration survival rate at 12 monthsFrom baseline to 12 monthRestoration survival rate at 12 months, defined as: At least 90% of restorations remaining in situ No statistically significant difference among groups according to FDI criteria

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORCansu Atalay, Assoc. Prof.

Hacettepe University

PRINCIPAL_INVESTIGATORAybüke Uslu Tekce, Assist. Prof.

Hacettepe University

PRINCIPAL_INVESTIGATORAyşe Rüya Yazıcı, Prof.

Hacettepe University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026